Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reiter

Showing results (331-340 of 386) with videos related to

Pageof 39
Sort By:
The Journal of Urology|December 2, 2021
Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate CancerAdam Kinnaird, Nitin K Yerram, Luke O'Connor, et al.
BMC Cancer|April 3, 2019
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic diseaseNeil R Parikh, Claudia Huiza, Jill S Patel, et al.
JAMA Oncology|September 16, 2021
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging TrialThomas A Hope, Matthias Eiber, Wesley R Armstrong, et al.
Frontiers in Oncology|March 6, 2015
MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy SpecimensMichael A Liss, Nathan S White, J Kellogg Parsons, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2020
Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate CancerNeil R Parikh, Amar U Kishan, Nathanael Kane, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2016
Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancerTanya Stoyanova, Mireille Riedinger, Shu Lin, et al.
Prostate Cancer and Prostatic Diseases|July 11, 2020
The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cellsNicholas G Nickols, Ekambaram Ganapathy, Christine Nguyen, et al.
JAMA Oncology|March 29, 2019
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialWolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
European Urology Oncology|June 20, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed TherapyJesus E Juarez Casillas, John Nikitas, Matthew B Rettig, et al.
Cancer|April 15, 2023
A novel prostate cancer subtyping classifier based on luminal and basal phenotypesAdam B Weiner, Yang Liu, Alex Hakansson, et al.
Pageof 39

Showing results (331-340 of 386) with videos related to

Sort By:
Pageof 39
The Journal of Urology|December 2, 2021
Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate CancerAdam Kinnaird, Nitin K Yerram, Luke O'Connor, et al.
BMC Cancer|April 3, 2019
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic diseaseNeil R Parikh, Claudia Huiza, Jill S Patel, et al.
JAMA Oncology|September 16, 2021
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging TrialThomas A Hope, Matthias Eiber, Wesley R Armstrong, et al.
Frontiers in Oncology|March 6, 2015
MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy SpecimensMichael A Liss, Nathan S White, J Kellogg Parsons, et al.
International Journal of Radiation Oncology, Biology, Physics|June 21, 2020
Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate CancerNeil R Parikh, Amar U Kishan, Nathanael Kane, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2016
Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancerTanya Stoyanova, Mireille Riedinger, Shu Lin, et al.
Prostate Cancer and Prostatic Diseases|July 11, 2020
The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cellsNicholas G Nickols, Ekambaram Ganapathy, Christine Nguyen, et al.
JAMA Oncology|March 29, 2019
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialWolfgang P Fendler, Jeremie Calais, Matthias Eiber, et al.
European Urology Oncology|June 20, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed TherapyJesus E Juarez Casillas, John Nikitas, Matthew B Rettig, et al.
Cancer|April 15, 2023
A novel prostate cancer subtyping classifier based on luminal and basal phenotypesAdam B Weiner, Yang Liu, Alex Hakansson, et al.
Pageof 39